Tests | % Agreement with microscopy(Kappa) | Sensitivity | Specificity | PPV | NPV |
---|---|---|---|---|---|
(95% CI) | (95% CI) | (95% CI) | (95% CI) | ||
Before treatment | |||||
HRP-2-RDTs | 80% | 96 | 72 | 66 | 97 |
(0.62) | (90.1, 98.9) | (62.1, 80.5) | (55.9, 75.2) | (91.5, 99.4) | |
Nested PCR | 85% | 98 | 78 | 72 | 98 |
(0.70) | (93.0, 99.8) | (68.8, 85.7) | (62.1, 80.5) | (93.0, 99.8) | |
LAMP | 84% | 98 | 77 | 71 | 98 |
(0.69) | (93.0, 99.8) | (67.5, 84.8) | (61.1, 79.6) | (93.0, 99.8) | |
On day 7 after first-line treatment | |||||
HRP-2-RDTs | 65% | 86 | 63 | 18 | 98 |
(0.18) | (77.6, 92.1) | (52.8, 72.4) | (11.0, 27.0) | (93.0, 99.8) | |
Nested PCR | 94% | 100 | 93 | 58 | 100 |
(0.70) | (96.4, 100) | (86.1, 97.1) | (47.7, 67.8) | (96.4, 100) | |
LAMP | 95% | 100 | 94 | 64 | 100 |
(0.75) | (96.4, 100) | (87.4, 97.8) | (53.8, 73.4) | (96.4, 100) |